In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
Self Employed on MSNOpinion
A Strategic Moment for U.S. Pharmaceutical Industry
The U.S. pharmaceutical industry, a leader in research and development, now faces an important opportunity: expanding into ...
Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...
4don MSN
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development
It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...
The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from the country, blaming insufficient government investment. Central to the ...
Innovation drives growth in the biotech and pharmaceutical space. According to The Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. biopharmaceutical sector directly supports ...
If you want a large pharmaceutical company to invent a new drug, your best bet is probably AstraZeneca. But if you have a medicine you’d like to get to market — and you want to see it generate revenue ...
Research and development (R&D) spending by drug manufacturers flatlined in 2022, according to data released by Evaluate Vantage Friday morning. Among the world’s largest 11 drugmakers, only ...
Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence In Pharmaceutical Market Report by Technology, Offering, Application, Deployment Mode, Countries and Company Analysis, 2025-2033 ...
Pharmaceutical companies are often lambasted for rising drug costs. For example, the price of new drugs entering the US market in 2023 was 35% higher than in 2022. According to an analysis from ...
China's pharmaceutical sector, once driven largely by generic drug production, is now witnessing a steady rise in innovative ...
NEW YORK (Reuters) -The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in order to cut drug costs in the United States, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback